PMID- 33658826 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220421 IS - 1178-7031 (Print) IS - 1178-7031 (Electronic) IS - 1178-7031 (Linking) VI - 14 DP - 2021 TI - AST-120 Improves Cardiac Dysfunction in Acute Kidney Injury Mice via Suppression of Apoptosis and Proinflammatory NF-kappaB/ICAM-1 Signaling. PG - 505-518 LID - 10.2147/JIR.S283378 [doi] AB - PURPOSE: Acute kidney injury (AKI) is a devastating disorder associated with considerably high morbidity and mortality. Reports have shown that AST-120, an oral charcoal adsorbent, can reduce oxidative stress by lowering serum indoxyl sulfate levels. The effects of AST-120 and indoxyl sulfate on kidney injury and cardiac dysfunction were investigated in vivo and in vitro. PATIENTS AND METHODS: Patients were tracked for enrollment upon receiving a diagnosis of AKI. Plasma was collected to determine the renal and inflammatory parameters. Renal ischemia/reperfusion (I/R) induced AKI or sham operation was performed in C57BL/6J mice. Animals were divided into sham, AKI+vehicle, and AKI+AST-120 groups. Plasma and tissues were assembled after 48 h to assess apoptotic and inflammatory responses. We also conducted human umbilical vein endothelial cell (HUVECs) and HL-1 cardiomyocyte culture studies to determine the underlying mechanisms of indoxyl sulfate's effects. Echocardiography, histopathology, biochemical indexes, ELISA, terminal dUTP nick-end labeling (TUNEL) and Western blot analysis were performed. RESULTS: The cohort included 25 consecutive patients with AKI and 25 non-AKI. Plasma levels of creatinine, indoxyl sulfate, IL-1beta and ICAM-1 were significantly higher in patients with AKI than in non-AKI controls. Plasma levels of blood urea nitrogen, creatinine, indoxyl sulfate, IL-1beta and renal tubular injury were increased in mice after renal I/R and were decreased by AST-120 treatment. In addition, AST-120 therapy not only improved the parameters assessed by echocardiography but also substantially attenuated the elevation of plasma BNP. Oral administration of AST-120 significantly downregulated NF-kappaB/ICAM-1 expression and reduced cell apoptosis in both kidney and heart after renal I/R injury. CONCLUSION: Our investigations demonstrated that AST-120 administration improves cardiac dysfunction in AKI mice via the suppression of apoptosis and proinflammatory NF-kappaB/ICAM-1 signaling. CI - (c) 2021 Shen et al. FAU - Shen, Wen-Ching AU - Shen WC AUID- ORCID: 0000-0003-0705-7467 AD - Department of Basic Medicine, Putian University, Putian City, Fujian Province, People's Republic of China. FAU - Chou, Yu-Hsiang AU - Chou YH AD - Department of Internal Medicine, National Taiwan University Hospital Jin-Shan Branch, New Taipei City, Taiwan. FAU - Shi, Li-Shian AU - Shi LS AD - Department of Biotechnology, National Formosa University, Yun-Lin, Taiwan. FAU - Chen, Zhi-Wei AU - Chen ZW AD - The Affiliated Hospital of Putian University, Putian City, Fujian Province, People's Republic of China. FAU - Tu, Hai-Jian AU - Tu HJ AD - The Affiliated Hospital of Putian University, Putian City, Fujian Province, People's Republic of China. FAU - Lin, Xin-Yi AU - Lin XY AD - Department of Basic Medicine, Putian University, Putian City, Fujian Province, People's Republic of China. FAU - Wang, Guei-Jane AU - Wang GJ AD - School of Medicine, Graduate Institute of Clinical Medical Science, China Medical University, Taichung, 40402, Taiwan. AD - School of Medicine, Graduate Institute of Biomedical Sciences, China Medical University, Taichung, 40402, Taiwan. AD - Department of Medical Research, China Medical University Hospital, Taichung, 40447, Taiwan. AD - Department of Health and Nutrition Biotechnology, Asia University, Taichung, 41354, Taiwan. LA - eng PT - Journal Article DEP - 20210224 PL - New Zealand TA - J Inflamm Res JT - Journal of inflammation research JID - 101512684 PMC - PMC7917393 OTO - NOTNLM OT - AST-120 OT - NF-kappaB OT - acute kidney injury OT - apoptosis OT - cardiac dysfunction OT - inflammation COIS- The authors declare that they have no competing interests. EDAT- 2021/03/05 06:00 MHDA- 2021/03/05 06:01 PMCR- 2021/02/24 CRDT- 2021/03/04 05:53 PHST- 2020/10/08 00:00 [received] PHST- 2021/01/09 00:00 [accepted] PHST- 2021/03/04 05:53 [entrez] PHST- 2021/03/05 06:00 [pubmed] PHST- 2021/03/05 06:01 [medline] PHST- 2021/02/24 00:00 [pmc-release] AID - 283378 [pii] AID - 10.2147/JIR.S283378 [doi] PST - epublish SO - J Inflamm Res. 2021 Feb 24;14:505-518. doi: 10.2147/JIR.S283378. eCollection 2021.